Genotypic distribution of human papillomavirus (HPV) and cervical cytology findings in 5906 Thai women undergoing cervical cancer screening programs

被引:24
|
作者
Kantathavorn, Nuttavut [1 ,4 ]
Mahidol, Chulabhorn [1 ,2 ,3 ]
Sritana, Narongrit [1 ]
Sricharunrat, Thaniya [1 ]
Phoolcharoen, Natacha [1 ,4 ]
Auewarakul, Chirayu [1 ,3 ]
Teerayathanakul, Narongchai [1 ]
Taepisitpong, Chantanee [1 ]
Saeloo, Siriporn [1 ]
Sornsamdang, Gaidganok [1 ]
Udomchaiprasertkul, Wandee [1 ]
Krongthong, Waraphorn [1 ]
Arnamwong, Arpaporn [1 ]
机构
[1] Chulabhorn Hosp, Bangkok, Thailand
[2] Chulabhorn Res Inst, Bangkok, Thailand
[3] Mahidol Univ, Fac Med, Siriraj Hosp, Bangkok 10700, Thailand
[4] Chulabhorn Hosp, Gynecol Oncol Unit, Bangkok 10210, Thailand
来源
INFECTIOUS AGENTS AND CANCER | 2015年 / 10卷
关键词
Cervical cancer; Cancer screening; HPV genotypes; Cervical cytology; Thailand; PREVALENCE; INFECTION; VACCINATION; DNA; PROVINCE;
D O I
10.1186/s13027-015-0001-5
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Cervical cancer is the major cause of morbidity and mortality in Thai women. Nevertheless, the preventive strategy such as HPV vaccination program has not been implemented at the national level. This study explored the HPV prevalence and genotypic distribution in a large cohort of Thai women. Methods: A hospital-based cervical cancer screening program at Chulabhorn Hospital, Bangkok and a population-based screening program at a rural Pathum Thani Province were conducted using liquid-based cytology and HPV genotyping. Results: Of 5906 women aged 20-70 years, Pap smear was abnormal in 4.9% and the overall HPV prevalence was 15.1%, with 6.4% high-risk (HR), 3.5% probable high-risk (PR), and 8.4% low-risk (LR) HPV. The prevalence and genotypic distribution were not significantly different between the two cohorts. Among HR-HPV genotypes, HPV52 was the most frequent (1.6%), followed by HPV16 (1.4%), HPV51 (0.9%), HPV58 (0.8%), HPV18 (0.6%), and HPV39 (0.6%). Among LR-HPV genotypes, HPV72 and HPV62 were the most frequent while HPV6 and HPV11 were rare. HPV infection was found to be proportionately high in young women, aged 20-30 years (25%) and decreasing with age (11% in women aged > 50). The more severe abnormal cytology results, the higher positivity of HR-HPV infection was observed. Conclusions: In conclusion, HPV52, HPV16, and HPV51 were identified as the most common HR-HPV genotypes in Thai women. This study contributes genotypic evidence that should be essential for the development of appropriate HPV vaccination program as part of Thailand's cervical cancer prevention strategies.
引用
收藏
页数:9
相关论文
共 50 条
  • [31] Distribution of HPV genotypes in cervical intraepithelial lesions and cervical cancer in Tanzanian women
    Vidal, Adriana C.
    Murphy, Susan K.
    Hernandez, Brenda Y.
    Vasquez, Brandi
    Bartlett, John A.
    Oneko, Olola
    Mlay, Pendo
    Obure, Joseph
    Overcash, Francine
    Smith, Jennifer S.
    van der Kolk, Mike
    Hoyo, Cathrine
    INFECTIOUS AGENTS AND CANCER, 2011, 6
  • [32] Human Papillomavirus Genotypes Distribution in High-Grade Cervical Lesions and Invasive Cervical Carcinoma in Women Living in Mauritania: Implications for Cervical Cancer Prevention and HPV Prophylactic Vaccination
    Abdoudaim, Mariem Salma
    Abdellahi, Mohamed Val Mohamed
    Baba, Nacer Dine Mohamed
    Bouassa, Ralph-Sydney Mboumba
    Ahmed, Mohamed Lemine Cheikh Brahim
    Belec, Laurent
    DIAGNOSTICS, 2024, 14 (17)
  • [33] Human papillomavirus-based screening at extended intervals missed fewer cervical precancers than cytology in the HPV For Cervical Cancer (HPV FOCAL) trial
    Gottschlich, Anna
    Gondara, Lovedeep
    Smith, Laurie W.
    Cook, Darrel
    Martin, Ruth Elwood
    Lee, Marette
    Peacock, Stuart
    Proctor, Lily
    Stuart, Gavin
    Krajden, Mel
    Franco, Eduardo L.
    van Niekerk, Dirk
    Ogilvie, Gina
    INTERNATIONAL JOURNAL OF CANCER, 2022, 151 (06) : 897 - 905
  • [34] Human papillomavirus test with cytology triage in organized screening for cervical cancer
    Veijalainen, Olga
    Kares, Saara
    Kujala, Paula
    Tirkkonen, Mika
    Vuento, Risto
    Kholova, Ivana
    Luukkaala, Tiina
    Osuala, Veronika
    Maenpaa, Johanna
    ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 2016, 95 (11) : 1220 - 1227
  • [35] Optimal Cervical Cancer Screening in Women Vaccinated Against Human Papillomavirus
    Kim, Jane J.
    Burger, Emily A.
    Sy, Stephen
    Campos, Nicole G.
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2017, 109 (02):
  • [36] Human papillomavirus genotypes distribution among Gabonese women with normal cytology and cervical abnormalities
    Zoa Assoumou, Samira
    Mbiguino, Angelique Ndjoyi
    Mabika, Barthelemy Mabika
    Ogoula, Sidonie Nguizi
    El Mzibri, Mohammed
    Khattabi, Abdelkrim
    Mustapha Ennaji, My
    INFECTIOUS AGENTS AND CANCER, 2016, 11
  • [37] Human papillomavirus type-distribution in cervical cancer in China: the importance of HPV 16 and 18
    Chen, Wen
    Zhang, Xun
    Molijn, Anco
    Jenkins, David
    Shi, Ju-Fang
    Quint, Wim
    Schmidt, Johannes E.
    Wang, Ping
    Liu, Yu-Ling
    Li, Lian-Kun
    Shi, Hong
    Liu, Ji-Hong
    Xie, Xing
    Niyazi, Mayinuer
    Yang, Pei
    Wei, Li-Hui
    Li, Long-Yu
    Li, Jie
    Liu, Jin-Feng
    Zhou, Qi
    Hong, Ying
    Li, Li
    Li, Qing
    Zhou, Hong-Lin
    Bian, Mei-Lu
    Chen, Jing
    Qiao, You-Lin
    Smith, Jennifer S.
    CANCER CAUSES & CONTROL, 2009, 20 (09) : 1705 - 1713
  • [38] Utilization of Human Papillomavirus DNA Detection for Cervical Cancer Screening in Women Presenting With Abnormal Cytology in Lokoja, Nigeria
    Kolawole, Olatunji
    Ogah, Jeremiah
    Alabi, Olatunde
    Suleiman, Mustapha
    Amuda, Oluwatomi
    Kolawole, Folashade
    JUNDISHAPUR JOURNAL OF MICROBIOLOGY, 2015, 8 (10)
  • [39] Cervical cancer and human papillomavirus in indigenous Guyanese women
    Kightlinger, Rebecca S.
    Irvin, William P.
    Archer, Kellie J.
    Huang, Nancy W.
    Wilson, Raeleen A.
    Doran, Jacqueline R.
    Quigley, Neil B.
    Pinkerton, JoAnn V.
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2010, 202 (06) : 626.e1 - 626.e7
  • [40] Human papillomavirus (HPV) DNA and mRNA primary cervical cancer screening: Evaluation and triaging options for HPV-positive women
    Sangrajrang, Suleeporn
    Laowahutanont, Piyawat
    Wongsena, Metee
    Muwonge, Richard
    Imsamran, Weerawut
    Ploysawang, Pattama
    Basu, Partha
    JOURNAL OF MEDICAL SCREENING, 2019, 26 (04) : 212 - 218